Rosa Morlà

731 total citations
25 papers, 448 citations indexed

About

Rosa Morlà is a scholar working on Rheumatology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Rosa Morlà has authored 25 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Rheumatology, 7 papers in Pathology and Forensic Medicine and 5 papers in Hematology. Recurrent topics in Rosa Morlà's work include Rheumatoid Arthritis Research and Therapies (15 papers), Autoimmune and Inflammatory Disorders Research (5 papers) and Salivary Gland Disorders and Functions (5 papers). Rosa Morlà is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (15 papers), Autoimmune and Inflammatory Disorders Research (5 papers) and Salivary Gland Disorders and Functions (5 papers). Rosa Morlà collaborates with scholars based in Spain, Mexico and United States. Rosa Morlà's co-authors include Ricard Cervera, Manuel Ramos‐Casals, M Ingelmo, Mario García‐Carrasco, Josep Font, Olga Trejo, Raimón Sanmartí, Sònia Jiménez, Jordi Yagüe and J. Rosas and has published in prestigious journals such as Annals of the Rheumatic Diseases, Medicine and Arthritis Research & Therapy.

In The Last Decade

Rosa Morlà

25 papers receiving 435 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Rosa Morlà 250 171 82 71 68 25 448
L Casatta 186 0.7× 98 0.6× 66 0.8× 36 0.5× 14 0.2× 12 379
Yan Geng 239 1.0× 70 0.4× 64 0.8× 21 0.3× 31 0.5× 46 497
Masatoshi Takaya 111 0.4× 117 0.7× 45 0.5× 39 0.5× 52 0.8× 51 401
Ben Ponvilawan 59 0.2× 48 0.3× 59 0.7× 37 0.5× 70 1.0× 75 445
Susumu Nishiyama 135 0.5× 125 0.7× 76 0.9× 23 0.3× 13 0.2× 42 356
Francesca Ometto 300 1.2× 70 0.4× 56 0.7× 36 0.5× 102 1.5× 29 524
Béatrice Pallot-Pradès 334 1.3× 40 0.2× 59 0.7× 46 0.6× 75 1.1× 24 594
Verônica Silva Vilela 247 1.0× 26 0.2× 86 1.0× 43 0.6× 136 2.0× 18 440
Darcy S. Majka 463 1.9× 56 0.3× 23 0.3× 29 0.4× 94 1.4× 15 647
C Dostál 347 1.4× 29 0.2× 32 0.4× 59 0.8× 59 0.9× 37 547

Countries citing papers authored by Rosa Morlà

Since Specialization
Citations

This map shows the geographic impact of Rosa Morlà's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Morlà with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Morlà more than expected).

Fields of papers citing papers by Rosa Morlà

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa Morlà. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Morlà. The network helps show where Rosa Morlà may publish in the future.

Co-authorship network of co-authors of Rosa Morlà

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa Morlà. A scholar is included among the top collaborators of Rosa Morlà based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa Morlà. Rosa Morlà is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Augé, Josep M., Andrés Ponce, Juan Camilo Sarmiento-Monroy, et al.. (2023). Calprotectin in Patients with Rheumatic Immunomediated Adverse Effects Induced by Checkpoints Inhibitors. Cancers. 15(11). 2984–2984. 2 indexed citations
3.
Ponce, Andrés, Virginia Ruíz-Esquide, Rosa Morlà, et al.. (2022). High Sensitivity C Reactive Protein in Patients with Rheumatoid Arthritis Treated with Antibodies against IL-6 or Jak Inhibitors: A Clinical and Ultrasonographic Study. Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona). 6 indexed citations
4.
Ponce, Andrés, J. Inciarte-Mundo, Rosa Morlà, et al.. (2022). Plasma calprotectin as a biomarker of ultrasound synovitis in rheumatoid arthritis patients receiving IL-6 antagonists or JAK inhibitors. Therapeutic Advances in Musculoskeletal Disease. 14. 1759720X221114105–1759720X221114105. 5 indexed citations
5.
Ponce, Andrés, Juan Camilo Sarmiento-Monroy, Rosa Morlà, et al.. (2022). Imaging Findings in Patients with Immune Checkpoint Inhibitor-Induced Arthritis. Diagnostics. 12(8). 1961–1961. 19 indexed citations
6.
7.
Morlà, Rosa, et al.. (2022). AB0283 FATIGUE AND DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS. A RESIDUAL FATIGUE OF HIGH LEVEL CAN BE OBSERVED EVEN IN LOW DISEASE ACTIVITY.. Annals of the Rheumatic Diseases. 81. 1268–1268. 2 indexed citations
8.
Sanmartí, Raimón, Rosa Morlà, Raúl Castellanos‐Moreira, et al.. (2021). Palindromic Rheumatism: Just a Pre-rheumatoid Stage or Something Else?. Frontiers in Medicine. 8. 657983–657983. 13 indexed citations
9.
Morlà, Rosa, Tengfei Li, Isabel Castrejón, George Luta, & Theodore Pincus. (2020). Multidimensional Health Assessment Questionnaire as an Effective Tool to Screen for Depression in Routine Rheumatology Care. Arthritis Care & Research. 73(1). 120–129. 12 indexed citations
10.
Castellanos‐Moreira, Raúl, S. C. Rodriguez-García, María J. Gómara, et al.. (2020). Anti-carbamylated protein antibody isotype pattern differs between palindromic rheumatism and rheumatoid arthritis. Therapeutic Advances in Musculoskeletal Disease. 12. 1759720X20978139–1759720X20978139. 6 indexed citations
11.
Castellanos‐Moreira, Raúl, S. C. Rodriguez-García, José A. Gómez‐Puerta, et al.. (2019). Rheumatoid Arthritis Initiating as Palindromic Rheumatism: A Distinct Clinical Phenotype?. The Journal of Rheumatology. 47(5). 652–657. 9 indexed citations
12.
Moreno, Mireia, Jordi Gratacós, Vicenç Torrente-Segarra, et al.. (2019). Withdrawal of infliximab therapy in ankylosing spondylitis in persistent clinical remission, results from the REMINEA study. Arthritis Research & Therapy. 21(1). 88–88. 23 indexed citations
13.
Corominas, Hèctor, Cayetano Alegre, Javier Narváez, et al.. (2019). Correlation of fatigue with other disease related and psychosocial factors in patients with rheumatoid arthritis treated with tocilizumab. Medicine. 98(26). e15947–e15947. 24 indexed citations
14.
Hernández, M.V., Stéphanie Rodriguez, Rosa Morlà, et al.. (2018). AB1332 Factors associated to persistence on golimumab in patients with inflammatory arthritis of the biobadaser registry. Annals of the Rheumatic Diseases. 77. 1755–1756. 1 indexed citations
15.
16.
Corominas, Hèctor, Vera Ortiz-Santamaría, I. Castellví, et al.. (2015). Nailfold capillaroscopic findings in primary Sjögren’s syndrome with and without Raynaud’s phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies. Rheumatology International. 36(3). 365–369. 14 indexed citations
17.
Ramos‐Casals, Manuel, Mario García‐Carrasco, Ricard Cervera, et al.. (2000). Thyroid Disease in Primary Sjögren Syndrome: Study in a Series of 160 Patients. Medicine. 79(2). 103–109. 59 indexed citations
18.
Morlà, Rosa, Manuel Ramos‐Casals, Mario García‐Carrasco, et al.. (1999). Nodular regenerative hyperplasia of the liver and antiphospholipid antibodies: report of two cases and review of the literature. Lupus. 8(2). 160–163. 30 indexed citations
19.
García‐Carrasco, Mario, Ricard Cervera, J. Rosas, et al.. (1999). Primary Sjögren's syndrome in the elderly: clinical and immunological characteristics. Lupus. 8(1). 20–23. 56 indexed citations
20.
Ramos‐Casals, Manuel, Ricard Cervera, Jordi Yagüe, et al.. (1998). Cryoglobulinemia in primary Sjögren's syndrome: Prevalence and clinical characteristics in a series of 115 patients. Seminars in Arthritis and Rheumatism. 28(3). 200–205. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L Casatta Breakdown of academic impact, for papers by Yan Geng Breakdown of academic impact, for papers by Masatoshi Takaya Breakdown of academic impact, for papers by Ben Ponvilawan Breakdown of academic impact, for papers by Susumu Nishiyama Breakdown of academic impact, for papers by Francesca Ometto Breakdown of academic impact, for papers by Béatrice Pallot-Pradès Breakdown of academic impact, for papers by Verônica Silva Vilela Breakdown of academic impact, for papers by Darcy S. Majka Breakdown of academic impact, for papers by C Dostál
Rankless by CCL
2026